Enhancer ID: | E_02_0313 |
Species: | human |
Position : | chr7:148804760-148806760 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Nothing |
Pubmed ID: | 29752567 |
Enhancer experiment: | Western blot,Quantitative real?time polymerase chain reaction(qRT?PCR),Caspase?9 activity assay,TUNEL,siRNA |
Enhancer experiment description: | EZH2 is upregulated, whereas inhibiting EZH2 exerted rescuing effect in anesthetics (bupivacaine)-induced spinal cord DRG. The possible downstream target of EZH2 inhibition may interact with caspase and TrkC signaling pathways. |
Target gene : | EZH2 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | EZH2 is upregulated, whereas inhibiting EZH2 exerted rescuing effect in anesthetics (bupivacaine)-induced spinal cord DRG. The possible downstream target of EZH2 inhibition may interact with caspase and TrkC signaling pathways. |
TF name : | -- |
TF experiment: | Western blot,Quantitative real?time polymerase chain reaction(qRT?PCR),Caspase?9 activity assay,TUNEL,siRNA |
TF experiment description: | EZH2 is upregulated, whereas inhibiting EZH2 exerted rescuing effect in anesthetics (bupivacaine)-induced spinal cord DRG. The possible downstream target of EZH2 inhibition may interact with caspase and TrkC signaling pathways. |
Enhancer function : | EZH2 is upregulated, whereas inhibiting EZH2 exerted rescuing effect in anesthetics (bupivacaine)-induced spinal cord DRG. The possible downstream target of EZH2 inhibition may interact with caspase and TrkC signaling pathways. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
EZH2 is upregulated, whereas inhibiting EZH2 exerted rescuing effect in anesthetics (bupivacaine)-induced spinal cord DRG. The possible downstream target of EZH2 inhibition may interact with caspase and TrkC signaling pathways. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|